Morphological changes of parotid glands following adjuvant arthritis and ibuprofen treatment in rats

International Journal of Oral and Maxillofacial Surgery

Volumn 32, Issue 1, 2003, Pages 69-73

  Mourouzis, C ^a,b   Saranteas, T ^a   Tsamouris, M ^c   Tesseromatis, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

^c Department of Pathology   (Greece)

Author keywords

Adjuvant arthritis; Ibuprofen; Parotid gland

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; RHEUMATOID FACTOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADJUVANT ARTHRITIS; ADRENAL GLAND; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FOOT; HISTOPATHOLOGY; MALE; MORPHOLOGY; NONHUMAN; ORGAN WEIGHT; PAROTID GLAND DISEASE; PAROTITIS; PROTEIN BLOOD LEVEL; RAT; REVIEW; SALIVARY GLAND DISEASE;

EID: 0037291611     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijom.2002.0338     Document Type: Review

References (26)

1. ABREMSON SR, WEISMANN G. The mechanism of action of NSAIDs. Arth Rheum 1989: 32: 1-9.
2. BENDELE AM. Animals models of rheumatoid arthritis. J Muscoskel Neuron Interact 2001: 1: 377-385.
3. CARAMAN P, NETTER P, SEMIN-COSSON AM, PARROT B, TRECHON P, AZOULAY E. Recurrent parotitis with H2 receptor antagonism. Lancet 1986: 2: 1455-1456.
4. DONALSON LF, SECKL JP, MCQUEEN DS. A descrete adjuvant-induced monoarthrtis in the rat: effects of adjuvant dose. J Neurosci Methods 1993: 49: 1-2, 5-10.
5. HANYU T, CHORANAPHUTI T, ARAI K, TANAKA T, TAKAHASHI HE. Histomorphometric assessment of bone changes in rats with type II collagen-induced arthritis. Bone 1999: 24: 485-490.
6. HELMANN D, STONE J. Arthritis and musculoskeletal disorders. In: Lewrence T, Mc Phee S, Papadakis M, eds: Current Medical Diagnosis. Stamford, Connecticut Appleton and Lungs 1999: 805-811.
7. HUNT DW, CORSON L, BARKER HD, LEVY JG, PETTY RE. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat. J Autoimmun 1993: 6: 691-700.
8. ILLES P, JURNA I, KAEVER V, RESCH K. Antiphlogistika: nicht steroidale antiphlogistika. In: Henschler D, Rummel W, Starke K, eds: Allgemeine und spezielle pharmakologie und toxikologie. Vol. 1. Heidelberg: Akademischer Verlag GmbH 1996: 220.
9. IMURA H, FUKATA J, MORI T. Cytokines and endocrine function: An interaction between the immune and neuroendocrine hormone. Endocrin Clin 1991: 35: 107-115.
10. KLEIN RM. Beta-adrenergic drug induced hyperplasia in the immature rat parotid and submandibular glands. Eur J Pharmacol 1984: 105: 327-331.
11. MACGREGOR A. HLA-DRB1 0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset and disease severity. J Rheumatol 1995: 22: 1032.
12. MANDEL L, SURATTANONT F. Bilateral parotid swelling: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002: 93: 221-237.
13. MASSIMO C, SEBASHANELLI G, NOERA G. Nifedipine induced parotitis: a hypersensitivity reaction. Am J Cardiology 1988: 61: 874.
14. O'BRIEN WM, BAGBY GF. Rare adverse reactions to nonsteroidal anti-inflammatory drugs. J Rheumatol 1985: 12: 13-20.
15. PEARSON CM. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proceeding of the Society for experimental biology 1956: 91: 95-101.
16. PELLINEN TJ, KALSKE J. Nitrofurantoin induced parotitis. Br Med J 1982: 285: 344.
17. ROUJEAU JC. Clinical aspects of skin reactions to NSAIDs. Scand J Rheumatol Suppl 1987: 65: 131-134.
18. RUPPERT G, BARTH WF. Ibuprofen hypersensitivity in systemic lupus erythematosus. South Med J 1981: 74: 241-243.
19. SEIFERT G, MIEHLKE A, HAUBRICH J, CHILLA R. Differential diagnosis of salivary swellings. In: Diseases of the Salivary Glands. New York: Thieme Inc. 1986: 322-323.
20. SHIP JA. Diagnosing, managing, and preventing salivary gland disorders. Oral dis 2002: 8: 77-89.
21. SCHACHT E. Present and future therapeutic strategies in rheumatoid arthritis. J Rheumatol 1993: 52: 365-382.
22. THOMPSON DF. Drug induced parotitis. J Clin Pharm Ther 1993: 18: 255-258.
23. VAN DEN BERG WB. Animals models in arthritis. In: Maddison PJ, Isenberg DA, Woo P, Glass D, eds: Oxford Textbook of Rheumatology. Oxford University Press 1998: 561-563.
24. VAN DE LANGERIJT AG, VAN LENT PL, HERMUS AR, SWEEP CG, COOLS AR, VAN DEN BERG WB. Susceptibility to adjuvant arthritis: relative importance of adrenal activity and bacterial flora. Clin Exp Immunol 1994: 97: 33-38.
25. VESELSKY L, ZELEZNA B, DOSTAL J, STANCIKOVA M, SVIK K, ROKYTA R, JURCOVICOVA J. Suppression of adjuvant arthritis in rats by boar seminal immunosuppressive fraction. Clin Exp Rheumatol 2001: 19: 153-158.
26. VISEUX V, BEGUIN L, POULAIN JF, SARRAJ A, MAYEUX I, CARMI E, LAFON B, LOK C. Phenylbutazone-induced sialadenitis fever simulating angioedema. Ann Dermatol Venereol 2002: 129: 59-62.